Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Cutting Edge Medication Assisted Opioid Addiction Treatment Center Opens On Chicago's North Shore

Soft Landing Recovery's outpatient treatment program offers one of the highest success rates in the Nation in beating opioid addiction


News provided by

Soft Landing Recovery

Sep 12, 2016, 03:44 ET

Share this article

Share toX

Share this article

Share toX

HIGHLAND PARK, Ill., Sept. 12, 2016 /PRNewswire/ -- According to the Center for Disease Control, overdose from opioids is now the leading cause of death in people under the age of 50 years old.  Soft Landing Recovery (SLR), a federally-licensed and regulated Opioid Treatment Program, has opened a new location in Downtown Highland Park, IL (1910 First Street, Suite 2N), to help fight opioid and prescription medication dependence as well as addiction to other drugs and alcohol. The program offers an innovative and highly-effective approach to medication assisted treatment (MAT), integrating buprenorphine-based medications and evidence-based behavioral health interventions, and boasts success rates four times industry averages.  SLR's services are covered by most commercial insurance companies, and include psychiatric services, individual, group and family counseling. 

The opening of SLR Highland Park is in response to a growing need on Chicago's North Shore and surrounding communities in northern Cook and Lake Counties. Unlike traditional recovery centers and rehab programs, SLR specializes in opioid addiction treatment and provides it in a high-end outpatient setting, with a program designed to treat the whole person, not just the addiction.

"Treatment for people suffering with addiction, and especially opioid abuse, needs a comprehensive, integrated approach that combines psychological, spiritual and biological methods of addressing the disease," says Chief Medical Officer, Dr. Abdel Fahmy, MD. "Aggressive medication assisted treatment is proving to be one of the most effective ways to mitigate the deadly pathology of opioid cravings."

To help ensure a complete and long-lasting recovery, SLR also incorporates massage therapy, acupuncture, yoga, hypnosis, meditation and other alternative therapies to alleviate stress and pain, promote physical and emotional wellness and stimulate the production of natural endorphins and other beneficial chemicals in the body.  SLR provides long-term care and will support patients and their families throughout their recovery journeys, providing counseling and physician support as long as required.

SLR provides all of these services, including IOP groups, on a confidential, outpatient basis.  "As a result, there's no checking into a hospital or residential facility, and no checking out from family and work. People with a stable home life and support system can go on with their lives throughout treatment. And, there's no sudden reentry into the 'real world' after treatment, reducing the risk of relapse," observes SLR's Regional Executive Director, Paul Getzendanner, JD, LCSW, CADC.

SLR Highland Park is easily accessible on the Metra line to serve patients from Chicago to Southeastern Wisconsin, and will complement the already highly successful programs established at SLR's Naperville and Des Plaines locations.

MEDICATION ASSISTED TREATMENT (MAT) 
Research shows that SLR's treatment model is scientifically designed to produce the best clinical outcomes. According to the American Society of Addiction Medicine (ASAM), effective, evidence-based treatment for opioid addiction "must include four basic elements: detoxification, rehabilitative counseling, continuing care, and Medication-Assisted Therapy."  According to Dr. Nora D. Volkow, Director of the National Institute on Drug Abuse (NIDA), MAT is regarded as the most effective treatment for opioid dependence and is "an essential component of an ongoing treatment plan, enabling opioid-addicted persons to regain control of their health and their lives."

Among MAT providers, SLR is unique, emphasizing buprenorphine-based medications, physician-driven, long-term treatment plans and evidence-based behavioral healthcare.  This integrated, medical-behavioral approach is precisely what proves to be most effective for patients struggling with opioid-use problems. 

Unlike a physician's office or group practice setting, where medications are prescribed with little or no counseling support or physician follow-up, SLR dispenses medications directly to patients who are committed to treatment and personal recovery.  Patients are only dispensed what they can safely handle.  Initially, patients will be given only 2-3 days of medication, gradually leading to monthly visits once the patient has demonstrated progress and the ability to manage that amount of medication.  SLR physicians do not 'estimate' appropriate levels of medication; rather, medication begins with a monitored induction, which is a deliberate process based on the patient's individual withdrawal symptoms, opioid cravings and detoxification goals.  Induction provides immediate relief from withdrawal symptoms, establishing a therapeutic dose of medication that permits the patient to focus on treatment and recovery.

As Dr. Fahmy explains: "Once evaluated, a small dose of medication is dispensed and monitored on site over a 2 to 4-hour period to see how the patient responds, and treatment and dosage can be adjusted up or down accordingly based on patient's feedback, which is a far more scientific and patient-friendly approach."

SLR's SUPERIOR PATIENT OUTCOMES  
Based on their dedication to state-of-the-art MAT with integrated physical, emotional and mental health services, SLR patients enjoy success rates that far exceed industry averages.  Compared to universal statistics for opioid-dependent patients where the relapse rate can be as high as 90 percent, only 13 percent of SLR patients have relapsed or returned-to-use at the one-year mark.  Moreover, 86 percent of SLR patients remain engaged and successful in treatment after six months, compared to other programs that typically experience dropout rates of 67 and 55 percent for outpatient and residential treatment, respectively. And, while overdose deaths have literally skyrocketed, SLR has a zero percent mortality rate.  In short, SLR provides patients and their families effective, evidence-based addiction treatment that produces the best results.

ABOUT SOFT LANDING RECOVERY
SLR is an innovative physician-driven drug treatment facility that first opened in DuPage County in 2007.  As a SAMHSA-certified and CARF-accredited Opioid Treatment Program (OTP), SLR is one of only a handful of facilities in Illinois offering ambulatory detoxification and is among the first to integrate the medical and behavioral aspects of patient care in a harmonious and collaborative model.

SLR is licensed by Illinois' Division of Alcohol and Substance Abuse, and is a member of the Lake County Opioid Initiative and Chicago Opioid Abuse Taskforce.

SLR Highland Park is located at 1910 First Street, Suite 2N, in Downtown Highland Park and has counselors available Monday to Friday from 9 a.m. to 7 p.m., and Saturday from 9 a.m. to 1 p.m. There is no waiting list and physicians are on call 24/7. Same-day appointments and walk-ins are welcome.

The public is encouraged to call Soft Landing Recovery's confidential hotline for a free, 15-minute phone consultation to discuss how they can help break the cycle of addiction: Toll-Free 1-888-782-6966; Highland Park 847-813-2559; Naperville 630-261-9220; Des Plaines 847-813-2558.

MEDIA CONTACT:
Ilyse Strongin-Bombicino 
312.285.7701 cell/847.432.4000 office
[email protected] 

WEBSITE:
www.softlandingrecovery.com

SOURCE Soft Landing Recovery

Related Links

http://www.softlandingrecovery.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.